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The placenta provides the interface for gas and
nutrient exchange between the mother and the fetus.
Despite its critical function in sustaining pregnancy,
the stem/progenitor cell hierarchy and molecular
mechanisms responsible for the development of
the placental exchange interface are poorly under-
stood. We identified an Epcamhi labyrinth tropho-
blast progenitor (LaTP) in mouse placenta that at a
clonal level generates all labyrinth trophoblast sub-
types, syncytiotrophoblasts I and II, and sinusoidal
trophoblast giant cells. Moreover, we discovered
that hepatocyte growth factor/c-Met signaling is
required for sustaining proliferation of LaTP during
midgestation. Loss of trophoblast c-Met also dis-
rupted terminal differentiation and polarization of
syncytiotrophoblasts, leading to intrauterine fetal
growth restriction, fetal liver hypocellularity, and
demise. Identification of this c-Met-dependent multi-
potent LaTP provides a landmark in the poorly
defined placental stem/progenitor cell hierarchy
and may help us understand pregnancy complica-
tions caused by a defective placental exchange.
INTRODUCTION
The mammalian placenta serves as the interface for gas and
nutrient exchange during development. The placenta also pro-
vides an immunological barrier between the fetus and the
mother and secretes hormones that regulate pregnancy. Recent
studies identified the placenta as a hematopoietic organ that
generates hematopoietic stem/progenitor cells (HS/PC) and
macrophages and provides a niche that protects definitive
HS/PC from premature erythroid differentiation (Gekas et al.,Developme2005; Rhodes et al., 2008; Van Handel et al., 2010; Chhabra
et al., 2012). Dysfunctional placental development has been
associated with maternal hypertension and preeclampsia
(Young et al., 2010), while disruption of placental circulation
and fetal-maternal exchange can lead to intrauterine fetal
growth restriction (IUGR) and demise (Scifres and Nelson,
2009). Therefore, proper placental function is critical for a
healthy pregnancy.
In the mouse placenta, substance exchange occurs in the
labyrinth (La; analogous to chorionic villi in human), which is
composed of highly branched fetal vasculature and tropho-
blast-lined maternal blood spaces (Figure S1A available online;
Rossant and Cross, 2001; Watson and Cross, 2005; Maltepe
et al., 2010). Trophoblasts are epithelial cells that develop from
the trophectoderm (Te), the outermost layer of the blastocyst.
Mitotic activity is limited to polar Te that differentiates into chori-
onic trophoblasts and the ectoplacental cone (EPC). Chorionic
trophoblasts form the labyrinth, while the EPC gives rise to the
junctional zone (JZ) consisting of spongiotrophoblasts (Sp) and
trophoblast giant cells (TGC) that provide structural support
and enable invasion to the uterus (Figure 1A; Figure S1A).
Morphogenesis of the labyrinth occurs after fusion of the allan-
toic mesoderm with chorionic trophoblasts (embryonic day 8.5
[E8.5]), which undergo extensive branching (Figure 1A). The lab-
yrinth consists of two layers of multinucleated syncytiotropho-
blasts (SynT-I and -II) that control fetal-maternal transport, and
sinusoidal trophoblast giant cells (sTGCs) that have endocrine
functions and act as hematopoietic signaling centers (Chhabra
et al., 2012). Fibroblast growth factor 4 (Fgf4)-dependent tropho-
blast stem (TS) cells that generate all trophoblast subtypes can
be established from the blastocyst and early postimplantation
embryos, and are the in vitro equivalents of Te (Tanaka et al.,
1998). However, TS cell potential disappears after chorioallan-
toic fusion (Uy et al., 2002) suggesting that yet unidentified pre-
cursors downstream of TS cells form the placenta (Figure 1A;
Simmons and Cross, 2005). Recent studies identified an EPC-
derived Blimp1+ precursor that generates multiple types of
TGC in the Sp layer (Mould et al., 2012). However, the precursorsntal Cell 27, 373–386, November 25, 2013 ª2013 Elsevier Inc. 373
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are unknown.
Targeted mutagenesis in mice has provided clues to mecha-
nisms regulating key stages of placental development (Rossant
and Cross, 2001; Watson and Cross, 2005). c-Met receptor tyro-
sine kinase and its ligand, hepatocyte growth factor (Hgf), have
been identified as regulators of labyrinth morphogenesis. Hgf
and c-Met knockout (KO) embryos exhibit IUGR and a smaller
placenta and die by E14.5; Bladt et al., 1995; Schmidt et al.,
1995; Uehara et al., 1995). c-Met signaling governs various
morphogenetic events in development, tissue repair, and cancer
metastasis by regulating cell growth and motility and stem/pro-
genitor cells in multiple tissues express c-Met (Boccaccio and
Comoglio, 2006). Nevertheless, little is known about the cellular
and molecular mechanisms of how c-Met signaling governs
placental development, and the extent to which placental
dysfunction underlies the defective development of c-Met-defi-
cient embryos.
Here we identify an Hgf/c-Met signaling-dependent Epcamhi
multipotent labyrinth progenitor that gives rise to all labyrinth
trophoblast subtypes. Trophoblast-specific loss of c-Met abro-
gated the proliferation of labyrinth trophoblast progenitors
(LaTPs) and terminal differentiation and polarization of syncytio-
trophoblasts, compromising both placental and fetal develop-
ment. These discoveries advance our understanding of placental
stem/progenitor cell hierarchy and provide an in vivo model for
studying how dysfunctional placental exchange compromises
pregnancy.
RESULTS
Epcam Marks Proliferative, Undifferentiated
Trophoblasts in the Placental Labyrinth
To identify candidate trophoblast progenitor cells in the placental
labyrinth, proliferative cellswere labeledwith bromodeoxyuridine
(BrdU) 1 hr before dissection, and immunofluorescence (IF) was
performed for BrdU and CD9 or Epcam (Trop1; Figure 1B; Fig-
ure S1A). CD9, a trophoblast marker upregulated at E10.5 during
labyrinth morphogenesis (Wynne et al., 2006), was expressed
broadly in syncytiotrophoblasts (SynT) in E12.5 labyrinth (Fig-
ure 1B; Figure S1A). In contrast, Epcam, amarker ofmany epithe-
lial stem cells (McQualter et al., 2010), was expressed highly in a
subset of labyrinth trophoblasts, while SynT showed low expres-
sion (Figure 1B; Figure S1A). Moreover, Epcamhi cells were ar-
ranged in clusters and showed much higher frequency of BrdU
incorporation than CD9+ cells (Figure 1B). To assess whether
Epcamhi cells are undifferentiated trophoblasts, sections were
costained for monocarboxylate transporter (Mct) 4, which is
expressed in the basal plasma membrane of SynT-II (Nagai
et al., 2010) adjacent to fetal vasculature.Mct4was undetectable
by IF at E10.5 (data not shown), whereas by E12.5, Mct4 colo-
calized with Epcam in SynT-II (Epcamlow; Figure 1C). In contrast,
Epcamhi cells were devoid of Mct4 expression (Figure 1C). At
E9.5, Epcamhi cells resided at the site of chorioallantoic fusion
(Figure 1D), and by E12.5, they formed clusters adjacent to
laminin+ stromal cells in the labyrinth. No Epcamhi cells were
detectable after completion of labyrinth morphogenesis at
E14.5 (Figure 1D). These data nominated Epcamhi cells as candi-
date progenitor cells in the placental labyrinth.374 Developmental Cell 27, 373–386, November 25, 2013 ª2013 ElsTo define the identity of Epcamhi cells, magnetic bead selec-
tion was used to isolate them from E10.5 placenta (Figure 1E;
Figure S1B). Fluorescence-activated cell sorting (FACS) analysis
confirmed the enrichment of Epcamhi cells without a significant
contribution of Epcamlow CD9hi SynT (Figure S1B). Results of
quantitative RT-PCR (qRT-PCR) indicated that the expression
of genes required for labyrinth trophoblast development,
including transcription factors Gcm1, Dlx3, and Ovol2 (Morasso
et al., 1999; Anson-Cartwright et al., 2000; Unezaki et al., 2007),
and orphan nuclear factor Nr6a1 (Morasso et al., 1999), was
enriched in Epcamhi fraction in E10.5 placenta as compared to
Epcam cells or TS cells (Figure 1F). Low expression of sTGC
markers (Ctsq and Prl3b) was detected in both Epcamhi and
Epcam cells, but not in TS cells, whereas TGC (Prl3d1) and
Sp (Tpbpa) markers were absent from both Epcamhi and TS cells
(Figure 1F). These data suggested that Epcamhi cells are primed
for differentiation to labyrinth trophoblasts.
Epcamhi Cells Represent Multipotent Labyrinth
Trophoblast Progenitors
To define the ability of Epcamhi cells to differentiate into labyrinth
trophoblasts, magnetic-activated cell-sorted Epcamhi cells were
cultured on OP9 stroma. OP9 cells highly express Vcam1, a
ligand for integrin a4 (Itga4), which is expressed both in Epcamhi
cells (Figure 2A) and on the basal surface of the chorion at the
time of chorioallantoic fusion (Stecca et al., 2002). The differen-
tiation potential of Epcamhi cells was compared to that of TS
cells, which upregulate markers for the SynT, Sp, and TGC line-
ages after removal of Fgf4 (Tanaka et al., 1998). After 7 days
of culture on OP9, Epcamhi cells maintained the expression of
SynT transcription factors Dlx3 and Ovol2 and upregulated the
mature SynT markers Mct1 (SynT-I) and Mct4 (SynT-II; Nagai
et al., 2010; Figure 2B) to greater levels than differentiated TS
cells, confirming the ability of Epcamhi cells to efficiently
generate SynT. Moreover, after 7 days in culture, E-cadherin+
(Cdh1) cells withmultiple nuclei (> 20) were observed (Figure 2C),
suggesting that SynT derived from Epcamhi cells can form
syncytia in vitro. Costaining with CD9 confirmed that the multi-
nucleated cells were trophoblasts (Figure 2D). Interestingly,
expression of sTGC markers Ctsq and Prl3b1 also increased
by 7 days of culture, suggesting that Epcamhi cells also differen-
tiate into labyrinth sTGC in vitro (Figure 2B). In contrast, cultured
Epcamhi cells evidenced minimal expression of TGC and Sp
markers, implying that their differentiation potential is restricted
to labyrinth trophoblasts. These data nominated Epcamhi cells
as labyrinth trophoblast progenitor cells (LaTP) that can give
rise to SynT-I, II, and sTGC.
We next asked if Epcamhi cells are clonally linked to SynT and
sTGC in vivo. Tamoxifen-inducible Rosa26-CreERT2 mice were
crossed with Rosa26-Rainbow reporter strain (Rinkevich et al.,
2011), in which all cells express GFP until Cre-mediated recom-
bination induces one of the three other fluorescent proteins
(mCherry, mOrange, and mCerulean; Figures 2E and 2F). 4-OH
tamoxifen was injected at E9.5 when labyrinth morphogenesis
begins, and placentas were analyzed at E12.5 when Epcamhi
cells and differentiated SynT and sTGC are present. To facilitate
clonal analysis, the dose of 4-OH tamoxifen was titrated to
induce rare recombination in trophoblasts. While individual cells
marked with mCherry, mOrange, or mCerulean were found in allevier Inc.
Figure 1. Epcamhi Cells Are Candidate LaTP Cells
(A) Schematic depicting the development of the mouse placenta. Polar trophectoderm (pTe) develops into ectoplacental cone (EPC) and chorion (Ch).
Trophoblast stem (TS) cells can established from trophoectoderm/placenta before E8.5, however, TS cells disappear after chorioallantoic fusion, suggesting that
yet unidentified progenitors are responsible for labyrinth development. The labyrinth (La) contains three trophoblast cell types: SynT-I, SynT-II, and sinusoidal
trophoblast giant cells (sTGCs). The SynT-II layer is facing fetal endothelium (End), and the sTGC is facing maternal blood. ICM, inner cell mass; De, decidua; Al,
allantois; CP, chorionic plate.
(B) Identification of Epcam as a marker for proliferating trophoblasts. Sections from E12.5 placental labyrinth were stained with CD9 or Epcam. DNA synthesis
was visualized by BrdU incorporation. Arrow, Epcamhi cluster. Arrowhead, SynT. Scale bar, 100 mm.
(C) Correlation of SynT-II differentiation marker, Mct4, with low Epcam expression in SynT-II (arrowhead). Arrow, Epcamhi cluster. Scale bar, 100 mm.
(D) Kinetic analysis of the frequency of Epcamhi cells in midgestation placentas. Scale bar, 100 mm.
(E) Enrichment of Epcamhi cells from E10.5 placenta using magnetic bead separation.
(F) Quantitative analysis of the expression of trophoblast subtype-specific genes in Epcamhi-enriched cells.
All error bars indicate SEM. See also Figure S1.
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Figure 2. Epcamhi Cells Represent Multipotent LaTPs
(A) Schematic for analysis of the developmental potential of Epcamhi cells in vitro. Epcamhi cells from E10.5 placenta were enriched using magnetic beads and
cocultured with OP9 for 7 days. qRT-PCR documents the expression of Itga4 in Epcamhi cells and Vcam1 in OP9.
(B) qRT-PCRshowing themaintenanceofSynT-specific genesandupregulationofmarkers for differentiatedSynT-I and -II and sTGC inEpcamhi cultures after 7days.
(C) Documentation of increased frequency of Cdh1+ SynT with multiple nuclei after 7 days in culture.
(D) Documentation that Cdh1+ multinucleated cells coexpress trophoblast marker CD9.
(E) Schematic for in vivo clonality analysis. Rosa26 (R26) Rainbow reporter mice were mated with R26 CreERT2 mice. At E9.5, Cre-mediated gene deletion was
induced by injection with 4OH-tamoxifen, and embryos were dissected at E12.5.
(F) Fluorescence image indicating that Cre-mediated gene recombination inducesmulti-color labeling and establishment of clones of labeled cells in the labyrinth.
JZ, junctional zone; La, labyrinth; Me, mesenchyme.
(legend continued on next page)
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ters of cells marked with the same color (Figure 2F). To investi-
gate differentiation potential of cells in individual clones,
mCherry-labeled clusters were chosen for further analysis (Fig-
ure 2G). Of all Epcamhi cell clusters, 2.2% (± 0.4) harbored
mCherry+ Epcamhi cells (Figure 2H), with each cluster containing
on average 4.8 (± 2.6) mCherry-labeled trophoblasts (Figure 2I).
Quantitative analysis indicated that 15.8% (± 4.1) of mCherry-
labeled clusters were multipotent and contained labeled clones
with Epcamhi LaTP, Epcamlow/neg SynT, and Epcamneg sTGC
(Figures 2G and 2J). Comparable results of clonal association
of Epcamhi LaTP with SynT and sTGC were obtained using
Rosa26-YFP reporter mice (Figures S2A–S2F). Costaining for
Epcam, Cytokeratin, and Mct4 further confirmed labeling of all
labyrinth trophoblast subtypes within YFP+-labeled Epcamhi
LaTP clusters (Figure S2G). Together, these data suggest that
Epcamhi cells are LaTPs that generate all labyrinth trophoblast
subtypes in vivo (Figure 2K).
c-Met Signaling Directly Regulates Labyrinth
Trophoblast Development
To identify regulators for LaTP, we searched for mouse models
with labyrinth defects; the Hgf receptor c-Met was identified as
a candidate. We first analyzed the placental defect in c-Met
KO embryos generated by deleting the conditionally targeted
c-Met locus (Huh et al., 2004) in the germline (g-KO). Lethality
of c-Met g-KO embryos occurred by E14.5, as reported for Hgf
and c-Met KO embryos (Bladt et al., 1995; Schmidt et al.,
1995; Uehara et al., 1995). No macroscopic defects were
observed in placentas or embryos until E12.5, when c-Met
g-KO placentas and embryos exhibited decreased size and
hypocellular fetal liver (FL; Figures S3A–S3D). c-Met g-KO
placentas had a thinner labyrinth (La) while the JZ composed
of Sp and TGC was unaffected (Figure 3A), confirming that
placental defects were limited to the labyrinth.
To assess whether loss of Hgf/c-Met signaling in placental tro-
phoblasts alone is sufficient to cause the defects in the placenta
and the fetus, we generated trophoblast-specific c-Met KO
(t-KO) embryos by deleting the c-Met gene in trophoblasts using
a lentiviral Cre (Figure 3B; Chhabra et al., 2012). UbiC-Cre-GFP
lentiviral vector was injected under the zona pellucida (ZP) of
c-Metfl/fl blastocysts, while c-Metfl/+ blastocysts and untrans-
duced c-Metfl/fl blastocysts served as controls. Strikingly,
trophoblast-specific c-Met deletion mimicked the phenotype of
c-Met g-KO mutants, resulting in reduced placental labyrinth
size and poorly developed branching structure (Figure S3E),
IUGR of the embryo (Figures 3C and 3D), and lethality by
E14.5 (data not shown). Moreover, loss of c-Met in placental tro-
phoblasts alone was sufficient to cause hypocellularity of the FL
(Figure S3F). Importantly, transduction of c-Metfl/+ blastocysts
did not show any phenotype in the embryo or the placenta(G) Documentation ofmultilineage differentiation in a cluster of mCherry-labeled tr
with large nuclei).
(H) Analysis of the frequency of clusters containing mCherry-labeled Epcamhi cel
(I) Average number of mCherry+ cells in a labeled cluster documenting the estab
(J) Differentiation potential of mCherry-labeled cells documenting the presence o
(K) Schematic representing the hierarchy of trophoblast lineage differentiation. L
All error bars indicate SEM. See also Figure S2.
Developme(data not shown). These findings indicate that trophoblast-spe-
cific loss of c-Met causes both labyrinth and FL hypoplasia
and IUGR of the embryo.
To examine how c-Met regulates labyrinth development, we
conducted Affymetrix microarray analysis on wild-type (WT)
and c-Met g-KO CD9+ labyrinth trophoblasts. We identified
1,294 genes as downregulated and 1,221 genes as upregulated
in c-Met-deficient trophoblasts (> 2-fold, p < 0.05; Tables S1 and
S2; Figure S3G). The GO category ‘‘placenta development’’
included genes regulating labyrinth development (Figure 3E;
Figure S3G). qRT-PCR confirmed reduced expression of SynT
genes (Gcm1, Dlx3, Ovol2, Cebpa, and Tead3; Natale et al.,
2006) in c-Met g-KO labyrinth trophoblasts (Figure 3F). qRT-
PCR of all E12.5 placentas showed that there was no reduction
in labyrinth sTGC- (Ctsq and Prl3b1), TGC- (Prl3b1, Limk1,
Limk2, and Hand1), or Sp-specific genes (Tpbpa and Nodal; Fig-
ure 3G; (Watson and Cross, 2005; Natale et al., 2006). These
data further indicated that c-Met signaling specifically regulates
labyrinth trophoblast development.
c-Met Sustains Proliferation of LaTP in Midgestation
Placenta
The selective suppression of SynT genes and the morphological
defects in the placental labyrinth raised the hypothesis that c-Met
signaling regulates the emergence, maintenance, and/or differ-
entiation of LaTP. qRT-PCR documented the expression of
c-Met in both Epcamhi LaTP and CD9hi Epcamlow/neg SynT,
whereas thematureSynTmarkerMct4wasexpressed at a higher
level in SynT (Figure 4A). The frequency of Epcamhi cells in c-Met
g-KOplacentawascomparable to that ofWTatE9.5, but dramat-
ically decreased from E10.5 onward (Figure 4B). These data
suggested that c-Met signaling is not required for specification
of LaTP, but rather for their maintenance through midgestation.
Themost highly enrichedGOcategories amonggenesdownre-
gulated in c-Met-deficient placentas were related to ‘‘cell cycle’’
(Figures S3G and S4A). qRT-PCR confirmed downregulation of
several genes required for cell division, including Ccna2, Ccne1,
Ccne2,Chek1, and Cdc45 (Figure 4C). BrdU incorporation assay
verified significant reduction in actively proliferating Cytokeratin+
trophoblasts in both c-Met g-KO and t-KO placentas at E12.5
(Figure S4B), whereas no difference in DNA fragmentation was
observed (Figure S4C), suggesting that defective proliferation
rather than apoptosis underlies labyrinth hypoplasia in c-Met-
deficient placentas. Costaining for phospho-Histone H3 (PH3),
a marker of mitosis, and Epcam showed no significant difference
in mitotic activity between WT and c-Met g-KO Epcamhi LaTP at
E9.5, whereas their proliferation was dramatically decreased
E10.5onward (Figure4D). Thesedata implied that c-Met signaling
is required to sustain the proliferation of LaTP in midgestation.
To verify that reduced proliferation of c-Met-deficient LaTP is
not caused by indirect effects from other tissues, c-Met signalingophoblasts. (i) Epcamhi (LaTP), (ii) SynT (Epcamlow/neg), and (iii) sTGC (Epcamneg
ls documenting infrequent labeling of clusters with the same fluorescent color.
lishment of multicellular, labeled clones.
f clones with Epcamhi LaTP and all labyrinth trophoblast subtypes.
aTP gives rise to all types of labyrinth trophoblasts, but not Sp or TGC.
ntal Cell 27, 373–386, November 25, 2013 ª2013 Elsevier Inc. 377
Figure 3. Loss of c-Met Signaling in Trophoblasts Induces Placental Labyrinth Hypoplasia and IUGR
(A) IF for Cytokeratin (green, trophoblast), Laminin (red, mesenchymal cell), and DAPI (blue, nuclei) on WT and c-Met germline KO (g-KO) placenta at E12.5
showing La-specific hypoplasia in c-Met g-KO placenta. Scale bar, 500 mm.
(B) Generation of trophoblast-specific c-Met KO (t-KO) embryos. Injection of Cre-GFP lentivirus under the zona pellucida (ZP) induces Te-specific gene deletion.
ICM, inner cell mass; Te, trophectoderm.
(C) Trophoblast-specific c-Met gene deletion induces placental labyrinth hypoplasia.
(D) Representative images of c-Metfl/fl and c-Met trophoblast-specific KO (t-KO) embryos and placentas. Numbers indicate size (in millimeters) of each embryo
and placenta. Scale bar, 1 mm.
(E) Heatmap representing differential expression of genes related to placental development (>2.0-fold, p < 0.05) in WT versus c-Met g-KO CD9+ trophoblasts.
(F) qRT-PCR for SynT-specific genes on E12.5 WT and c-Met g-KO CD9+ trophoblasts. The mean of biological replicates normalized to Gapdh is shown.
(G) qRT-PCR for sTGC, TGC, and Sp-specific genes in E12.5 placenta.
All error bars indicate SEM. See also Figure S3 and Tables S1 and S2.
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(Christensen et al., 2003). Inhibition of c-Met signaling impaired
the proliferation of Epcam+ cells in culture without increasing
apoptosis (Figures 4E and 4F), demonstrating a cell autonomous
role for c-Met in sustaining the proliferation of LaTP and/or their
progeny.378 Developmental Cell 27, 373–386, November 25, 2013 ª2013 Elsc-Met Signaling Is Essential for the Establishment of
Labyrinth Exchange Interface
Because the expression analysis of c-Met-deficient placentas
had indicated a dramatic reduction of labyrinth trophoblast-
specific transcription factors, we investigated whether c-Met
signaling is required for the differentiation of LaTP into SynTevier Inc.
Figure 4. c-Met Signaling Regulates the Maintenance of LaTP
(A) qRT-PCR documenting the expression of c-Met in both Epcamhi LaTP and Epcamlow SynT.
(B) IF for Epcam (green) and Laminin (red) on WT and c-Met g-KO placenta at E9.5, E10.5, and E12.5 documenting loss of Epcamhi cells in c-Met-deficient
placenta after E9.5. Arrows, Epcamhi cells adjacent to laminin+ mesenchymal cells. Scale bar, 100 mm.
(C) qRT-PCR analysis of gene expression in CD9+ trophoblast from WT and c-Met g-KO placentas verifying downregulation of cell cycle regulators.
(D) IF for Epcam (green), phospho-Histone-H3 (PH3, red) and laminin (blue) on WT and c-Met g-KO placenta at E9.5, E10.5, and E12.5 documenting premature
loss of proliferative LaTP in c-Met-deficient placenta. Arrows, PH3+ Epcamhi cells. Arrowheads, PH3+ Epcam cells. Scale bar, 50 mm.
(E) Treatment of cultured LaTP with c-Met inhibitor documents reduced BrdU incorporation in Epcam+ cells. Epcam (green), BrdU (red), DAPI (blue).
(F) Treatment of cultured LaTP with c-Met inhibitor documenting no difference in cell death of Epcam+ cells. Epcam (green), TUNEL (red), DAPI (blue). Positive
control, cells treated with DNase I.
All error bars indicate SEM. See also Figure S4.
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Figure 5. c-Met Signaling Is Dispensable for SynT and sTGC Specification but Essential for SynT Terminal Differentiation and Cell Polarity
(A) Electron microscopy showing trilaminar structure of labyrinth trophoblasts (SynT-I, SynT-II, and sTGC) in WT and c-Met g-KO placentas.
(B) Quantitative analysis for trophoblast subtypes.
(C) qRT-PCR showing decreased expression of Syna and Synb in E12.5 c-Met KO CD9+ trophoblasts.
(D) Heatmap of cell-cell junction genes differentially expressed between WT and c-Met g-KO CD9+ trophoblasts.
(E) qRT-PCR showing reduced expression of cell-cell junction and cell polarity genes in c-Met g-KO trophoblasts.
(legend continued on next page)
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c-Met-Dependent Labyrinth Trophoblast Progenitorand/or sTGC. Electron microscopy indicated that the trilaminar
trophoblast structure consisting of SynT-II, SynT-I, and sTGC
was established in c-Met g-KO placenta (Figure 5A). Costaining
for Mct4 (SynT-II) and CD9 (both SynT subtypes) confirmed the
presence of both SynT-I and -II in c-Met g-KO placentas (Fig-
ure S5A). Quantification of the relative frequencies of labyrinth
trophoblasts in c-Met g-KO placentas at E12.5 revealed a slight
decrease of SynT and increase of sTGC, while Epcamhi cells
were nearly undetectable (Figure 5B). Nevertheless, despite
the presence of both SynT-I and SynT-II in c-Met g-KO pla-
centas, the expression of Syncytin-a (Syna) and -b (Synb) that
mark terminally differentiated SynT-I and SynT-II, respectively,
was dramatically reduced, suggesting a defect in terminal differ-
entiation (Figure 5C). Microarray analysis and qRT-PCR revealed
reduced expression of genes encoding tight junction proteins
Cldn3, 6, 7, and 14, and Tjp3, adherence junction proteins
(Cdh1 [E-cadherin]), and gap junction proteins Gjb2 (Cx26) and
Gjb3 (Cx31), which are highly expressed in differentiated SynT
and critical for labyrinth development (Gabriel et al., 1998;
Plum et al., 2001; Figures 5D and 5E).
Epithelial cells exhibit apical-basolateral polarity that is essen-
tial for organ development and function (Martin-Belmonte and
Perez-Moreno, 2012). Closer examination of the CD9 staining
pattern in c-Met-deficient trophoblasts revealed that although
CD9 was localized on both the fetal side of SynT-II and maternal
(apical) side of SynT-I in WT placentas (Figure S5A), it was
diffusely localized in c-Met g-KO SynT, suggesting that c-Met
signaling regulates SynT cell polarity. Microarray analysis and
qRT-PCR revealed downregulation of polarity genes Crb3 and
aPKCz (Prkcz) in c-Met g-KO trophoblasts (Figure 5E). No statis-
tically significant reduction was observed by qRT-PCR for Pard3
and Pard6b (data not shown), which form a complex with Prkcz
to establish cell polarity in many cell types (Martin-Belmonte and
Perez-Moreno, 2012). Quantitative IF analysis documented
reduction of Prkcz protein in c-Met KO placenta (Figure 5F).
Moreover, while Prkcz was expressed at the fetal side of SynT-II
in WT placenta (Figure 5F), a more diffuse expression of the
residual Prkcz protein was observed in c-Met g-KO SynT-II.
Likewise, although Epcam expression in SynT in WT placenta
was confined to the membrane of the fetal (basal) side of
SynT-II (Figure 5G), in c-Met g-KO placenta, Epcam was
diffusely expressed. In the yolk sac, Epcam was distributed on
the basolateral membrane and CD9 was abundantly expressed
at the apical surface in both WT and c-Met g-KO (Figure S5B),
indicating that cell polarity was disrupted only in the placenta.
These data demonstrated a pivotal role for c-Met signaling in
the establishment of apical-basolateral cell polarity during
SynT differentiation.
Transplacental iron transport from the mother is critical for
normal fetal development. Serum iron is bound to transferrin(F) IF for Prkcz (green) and CD9 (red) showing polarized localization of Prkcz pro
expression of Prkcz in c-Met g-KO placenta. DAPI (blue, nuclei).
(G) IF for Epcam (green), CD9 (red), and DAPI (blue) onWT and c-Met g-KO placen
membrane of SynT-I. m, maternal blood space; f, fetal vascular lumen.
(H) IF for Epcam (green), CD71 (red), andDAPI (blue) on placental section at E12.5.
and c-Met g-KO placenta.
(I) FACS analysis indicating reduced surface expression of CD71 on SynT in c-M
All error bars indicate SEM. See also Figure S5.
Developme(Trf), and is taken up by transferrin receptor (CD71) via endocy-
tosis. After iron dissociation, Trf-CD71 complex is recycled to
the cell surface (Grant and Donaldson, 2009). CD71 is necessary
for fetal development (Levy et al., 1999), and the endocytic recy-
cling of CD71 is tightly regulated by cell polarity machinery
(Golachowska et al., 2010). IF and FACS analysis showed that
in WT placenta, CD71 is expressed in both the cytoplasm and
cell surface of SynT-I (Figures 5H and 5I). However, although
IF demonstrated abundant cytoplasmic expression of CD71 in
c-Met-deficient SynT-I (Figure 5H), FACS analysis revealed
drastic reduction of surface CD71 (Figure 5I). These data sug-
gested that impaired cell polarity in the c-Met KO placenta
causes abnormal subcellular distribution of CD71 and other pro-
teins required for fetal-maternal transport.
c-Met Signaling Is Required for the Maintenance of
Gcm1 Expression in Midgestation Placenta
Expression analysis of c-Met-deficient trophoblasts had indi-
cated a dramatic reduction of transcription factors regulating
SynT development; the analysis of trophoblast subtypes in
the labyrinth indicated that both SynT-I and SynT-II were spec-
ified in the absence of c-Met, but their terminal differentiation
was compromised. To investigate whether c-Met signaling
in trophoblasts is directly required for the expression of tran-
scription factors regulating labyrinth morphogenesis, cultured
Epcamhi cells were treated with c-Met inhibitor. qRT-PCR
revealed that blocking c-Met signaling in vitro in LaTP and their
progeny resulted in a drastically reduced expression of Gcm1,
but not Ovol2, Dlx3, or Tead3 (Figure 6A). IF verified the reduc-
tion of Gcm1 LaTP cultures treated with the c-Met inhibitor
(Figure 6B).
Gcm1 is a transcription factor essential for labyrinth morpho-
genesis and SynT differentiation (Anson-Cartwright et al., 2000;
Simmons et al., 2008). While Gcm1 is highly expressed in differ-
entiated, postmitotic SynT-II, Gcm1 expression has also been
reported in the chorion at E8.5 and in putative precursors of
the labyrinth trophoblasts at E9.5 (Basyuk et al., 1999; Hunter
et al., 1999; Stecca et al., 2002). qRT-PCR analysis of FACS-
sorted Epcamhi LaTP and Epcamlow CD9hi SynT cells from
E10.5 placenta documented Gcm1 expression in both fractions
(Figure S6A). In situ hybridization evidenced the expression
of Gcm1 also in Epcamhi LaTP at E10.5 (Figure S6B), whereas
by E14.5, Gcm1 expression was largely confined to SynT-II
(Figure S6C). IF suggested that Gcm1 is expressed in some
Epcamhi LaTP that are undergoing mitosis (Figure S6D).
These data imply that Gcm1 expression is not restricted to
differentiated, postmitotic SynT but begins already at the level
of LaTP.
To investigate whether Gcm1 expression is required for the
emergence and/or differentiation of LaTP, the expression oftein in fetal side of SynT-II in WT placenta (arrow), and diffuse and decreased
ta at E12.5. Arrows indicate fetal side of SynT-II and arrowheads indicate apical
Expression of cytoplasmic CD71 in SynT-I (arrowheads) is observed in bothWT
et g-KO placentas.
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Figure 6. c-Met Signaling Is Required to Maintain Gcm1 Expression in Midgestation Placenta
(A) qRT-PCR demonstrating loss of Gcm1 expression upon treatment of cultured LaTP with c-Met inhibitor.
(B) IF documenting loss of Gcm1 in Epcam+ cells upon treatment with c-Met inhibitor. Epcam (green), Gcm1 (red), DAPI (blue).
(C) IF documenting reduced labyrinth size in Gcm1 g-KO placenta. Scale bar, 100 mm. Epcam (green), laminin (red), DAPI (blue).
(D) Phospho-Histone H3 staining documenting reduction of mitotic Epcamhi cells (arrow) in Gcm1 KO placentas. Arrowheads, PH3 negative Epcamhi cluster.
Epcam (green), PH3 (red), DAPI (blue). Scale bar, 100 mm.
(E) TUNEL staining indicating apoptosis is not induced inGcm1 g-KO placenta at E10.5. Positive control for Tunel staining is shown below. Epcam (green), TUNEL
(red), DAPI (blue). Scale bar, 100 mm.
(F) IF showing absence of CD71+ SynT in Gcm1 g-KO placenta. Epcam (green), CD71 (red), DAPI (blue). Scale bar, 100 mm.
(G) qRT-PCR and (H) IF documenting loss of Gcm1 expression by E12.5 in c-Met g-KO placentas. Epcam (green), Gcm1 (red) DAPI (blue). Scale bar 100 mm.
All error bars indicate SEM. See also Figure S6.
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Figure 7. Model for Function of Hgf/c-Met
Signaling in the Development of Placental
Exchange Interface
LaTPs are responsible for the generation of SynT I
and II and sTGC that compose the placental
exchange interface. While LaTP can be specified
independently of c-Met signaling, c-Met is
essential for sustained proliferation of LaTP. c-Met
signaling is also required for the establishment of
SynT cell polarity. Loss of c-Met signaling results in
placental hypoplasia, a compromised exchange
interface, and defective fetal development.
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embryonic death. As reported previously (Anson-Cartwright
et al., 2000), the labyrinth layer wasmuch thinner, and no branch-
ingmorphogenesiswasobserved (Figure 6C).Notably,Gcm1KO
placentas harbored Epcamhi cells; however, the frequency of
PH3+ mitotic Epcamhi cells was drastically reduced (Figure 6D),
while no increase in apoptosis was revealed by TUNEL assay
(Figure 6E). Moreover, no CD71+ differentiating SynT were found
in Gcm1 KO placentas (Figure 6F). These data suggested that
complete lack of Gcm1 expression compromises both the
proliferation and differentiation of Epcamhi LaTP in vivo.
Because the placental phenotype in Gcm1 KO embryos was
much more severe than that in c-Met KO embryos, we investi-
gated the kinetics of Gcm1 expression in c-Met-deficient
placentas. At E9.5, there was no difference in the expression
of Gcm1 between c-Met deficient and WT placentas, whereas
by E12.5, Gcm1 expression in the mutant trophoblasts was
nearly undetectable with IF and qRT-PCR (Figures 6G and 6H).
These data suggested that c-Met is not essential for inducing
Gcm1 expression, but rather for maintaining its expression in
LaTP and SynT through midgestation. Altogether, these findings
identify Gcm1 as a key downstream effector of c-Met signaling,
and suggest that its continued expression in LaTP and/or SynT
in the midgestation placenta is required for the establishment
of a functional placental exchange interface.Developmental Cell 27, 373–386, NDISCUSSION
The stem/progenitor cell hierarchy of the
trophoblasts responsible for placental lab-
yrinthmorphogenesis andexchange func-
tion has been unknown. We discovered
that the midgestation mouse placenta
harbors Epcamhi multipotent labyrinth
trophoblast progenitors (LaTP) that differ-
entiate into all labyrinth trophoblast sub-
types, SynT-I, SynT-II, and sTGC, in vitro
and in vivo. We discovered that c-Met
signaling is required for sustained prolifer-
ation of LaTP during midgestation and
for terminal differentiation andpolarization
of SynT, which is a prerequisite for a
functional placental exchange interface
and healthy fetal development (Figure 7).
Clonal analysis using multicolor
Rainbow reporter mouse (Rinkevich et al.,2011) revealed that marking individual cells in the placenta results
in the generation of multicellular clusters that contain Epcamhi
LaTP, SynT-I, SynT-II, and sTGC. Although 15.8% of the labeled
trophoblast clusters identified at E12.5 (labeled at around E9.5)
were multipotent, 34.5% of all labeled the clusters contained
only undifferentiated Epcamhi LaTP, indicating that they had not
started to differentiate at this stage, while the remaining labeled
clones were composed of Epcamhi LaTP and SynT or sTGC
only. Future studies using marking at different time points will
revealwhether thedifferentiationpotential of LaTPchangesduring
development. Thus, studies should focus on creating a Cre line
that confers LaTP-specific labeling to lineage trace the progeny
of LaTP throughout development.
Our data show that both LaTP and SynT express c-Met, while
mesenchymal cells derived from the allantois secrete Hgf
(Uehara et al., 1995), suggesting paracrine signaling. Abrogation
of c-Met signaling disrupted the proliferation of Epcamhi cells
both in vivo and in vitro. Nevertheless, our data suggest that
Hgf/c-Met signaling is necessary, but not sufficient to support
LaTP proliferation and/or SynT differentiation without other
niche factors; culture of Epcamhi cells in TS cell conditions or
on Matrigel with Hgf failed to support SynT differentiation and
maintain Gcm1 expression. However, culture of Epcamhi cells
on OP9 mesenchymal stroma, which secretes Hgf and ex-
presses Vcam1 (Malhotra and Kincade, 2009) that is essentialovember 25, 2013 ª2013 Elsevier Inc. 383
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(Stecca et al., 2002), facilitated the maintenance/induction of
SynT genes and formation of multinucleated syncytia. Cultured
Epcamhi LaTP also induced genes specific for labyrinth sTGC,
which have been implicated as key hematopoietic niche cells
(Chhabra et al., 2012). These data imply that the Epcamhi cell
culture may be used to study the trophoblast subtypes that
establish the exchange interface and the hematopoietic niche
in the placental labyrinth. Future work will be needed to define
distinct niche components to direct the differentiation of LaTP
to specific labyrinth trophoblast subtypes and to investigate
whether LaTP can be sustained in an undifferentiated state in
culture.
Although previous studies had associated defective c-Met
signaling with disrupted labyrinth development, the underlying
mechanisms were unknown. Our data revealed a critical role
for c-Met in the maintenance of Gcm1 expression in midgesta-
tion placenta whereas the initial induction of Gcm1 occurs inde-
pendently of c-Met. This finding helps explain the less drastic
placental defect in c-Met KO embryos than in Gcm1 KO em-
bryos, because a complete lack of Gcm1 disrupted labyrinth
morphogenesis and SynT differentiation entirely, causing embry-
onic death by E10.5 (Anson-Cartwright et al., 2000). Analysis of
Gcm1 KO placentas suggested that Epcamhi LaTP can be spec-
ified in the absence of Gcm1, but their proliferation and differen-
tiation is disturbed. In contrast, loss of c-Met did not abolish the
expression of Gcm1 or cause macroscopic defects in c-Met KO
labyrinth until E12.5, when LaTP were extinguished and Gcm1
expression dropped to undetectable levels. Altogether, these
data suggest that the specification of LaTP is induced by a
c-Met- and Gcm1-independent mechanism; however, c-Met is
required for SynT terminal differentiation and establishment of
the placental exchange interface, which may at least in part be
linked to the requirement of c-Met signaling to maintain Gcm1
expression.
Previous studies have shown that Gcm1 is highly expressed
in postmitotic cells in the labyrinth and that overexpression of
Gcm1 induces cell cycle arrest (Hughes et al., 2004). Our data
also confirmed high expression of Gcm1 in differentiated
SynT-II. In addition, the ability to distinguish undifferentiated
LaTP in the labyrinth by Epcamhi staining identified a small pop-
ulation of proliferative LaTP that also expressGcm1. Because TS
cells do not express Gcm1, it is plausible that expression of
Gcm1 is important for LaTP commitment to the SynT lineage.
To verify if Gcm1 governs the differentiation of LaTP to SynT,
and/or is directly involved in maintaining LaTP proliferation,
further studies deleting Gcm1 in a cell-type-specific and tempo-
ral manner will be required.
As with mouse placenta, little is known about the stem/pro-
genitor cell hierarchy in the human placenta. Despite similarities
in molecular regulation, the mouse and human placentas are
macroscopically distinct (Georgiades et al., 2002). Thus, the
direct relevance of the findings of mouse LaTP to human
placental progenitor biology needs to be explored separately.
Recent studies documented that the chorionic membrane of
the first trimester human placenta can serve as a source of
trophoblast progenitor cell lines that highly express GCM1 and
upregulate SYNCYTIN after differentiation in vitro (Genbacev
et al., 2011), raising the hypothesis that they originate from a pre-384 Developmental Cell 27, 373–386, November 25, 2013 ª2013 Elscursor that has a parallel function in establishing the placental
exchange interface as the mouse LaTP.
Differentiated SynT form a ‘‘placental barrier’’ that tightly reg-
ulates the passage of substances between thematernal and fetal
circulations (Kokkinos et al., 2010). We showed that while c-Met-
deficient LaTP can form all labyrinth trophoblast subtypes, c-Met
is necessary for terminal differentiation into polarized SynT.
Trophoblast cell lines have provided a useful tool to study cell
polarity in vitro (Sivasubramaniyam et al., 2013); however, little
is known about the direct functional consequences of disrupted
SynT cell polarity in vivo. In addition to the low expression of key
cell polarity molecules and the inability to achieve polarized
localization of SynT surface proteins in c-Met KO placentas,
the surface localization of transferrin receptor (CD71), required
for transplacental iron transfer, on SynT-I was impaired. Future
studies are needed to define the mechanisms as to how the
disturbed placental exchange c-Met-deficient embryos causes
fetal liver hypocellularity, IUGR, and death of the fetus. Thus,
c-Met-deficient placentas not only offer a unique in vivo model
to investigate how the apical-basolateral polarity and bidirec-
tional transport in SynT is established, but may also help uncover
the etiology of pregnancy complications related to placental
transport function.
Reduced expression of Hgf has been observed in human pla-
centas from preeclampsia and IUGR pregnancies (Furugori
et al., 1997; Somerset et al., 1998), and in vitro studies demon-
strated that Hgf activates invasion of human trophoblasts
(Kauma et al., 1999; Nasu et al., 2000), providing evidence for
MET signaling in placental development and disease in human.
Moreover, similar to many human placenta-related disorders
such as spontaneous abortion, premature delivery, IUGR, and
preeclampsia that are accompanied by placental inflammation
(Young et al., 2010), c-Met deficiency in trophoblasts induced
inflammation andmacrophage infiltration in the placenta (unpub-
lished data). Although the mechanisms that trigger inflammation
in c-Met-deficient trophoblasts are still unknown, this may be
related to downregulation of cell-cell junction molecules and/or
defective cell polarity in SynT that compromise fetal-maternal
barrier function. Moreover, c-Met is constitutively activated in
human choriocarcinoma, and Hgf stimulates the proliferation of
choriocarcinoma cells (Saito et al., 1995; Takayanagi et al.,
2000). c-Met also regulates the proliferation and migration of
various other cancer cells and stem cells (Boccaccio and Como-
glio, 2006). Thus, defining how Hgf/c-Met signaling governs the
proliferation of stem/progenitor cells such as LaTP and the
establishment of cell polarity in their differentiated progeny
may have implications to understanding the pathophysiology
of other common diseases.EXPERIMENTAL PROCEDURES
Animals
All procedures with animals were conducted according to the guidelines of
the UCLA Animal Research Committee. For LaTP culture, E10.5 pregnant
mice (ICR, Taconic) were used. For the in vivo clonality experiments,
Rosa26-Rainbow reporter or Rosa26-YFP reporter mice were mated with
Rosa26-Cre-ERT2 mice. Pregnant females were injected with 0.5 mg 4-OH
tamoxifen at E9.5, and tissues were collected at E12.5. c-Metfl/fl mice
were provided by Dr. Snorri S. Thorgeirsson (NIH, Bethesda, MD, USA; Huh
et al., 2004). To generate trophoblast-specific c-Met KO embryos, lentiviralevier Inc.
Developmental Cell
c-Met-Dependent Labyrinth Trophoblast Progenitorvector-expressing Cre-Gfp was microinjected under the ZP of the blastocyst
and embryos were transplanted into pseudopregnant females, as shown
earlier (Chhabra et al., 2012). For details, see the Supplemental Experimental
Procedures. Sections of Gcm1 KO placentas were provided by Dr. James C.
Cross (University of Calgary, Calgary, Canada).
LaTP and TS Cell Culture
E10.5 placenta was digested with 1 mg/ml collagenase and 1 mg/ml dispase.
Epcamhi cells were enriched using anti-Epcam antibody and anti-rat IgG
magnetic beads. Epcamhi cells were cocultured with mitomycin C-treated
OP9 stroma cell with TS medium (RPMI 1640; Invitrogen) containing 20% fetal
calf serum (HyClone), 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml strep-
tomycin, 1 mM sodium pyruvate, and 100 mM b-mercaptoethanol) with or
without c-Met inhibitor, PHA665752 (4 mM, Sigma-Aldrich) for 7 days. TS cells
were maintained as described (Tanaka et al., 1998). TS cell differentiation was
induced by removing mouse embryonic fibroblast-conditioned medium, Fgf4,
and heparin for 7 and 10 days.
Immunofluorescence and In Situ Hybridization
Histology, BrdU incorporation assay, electron microscopy, qRT-PCR, and
immunofluorescence were performed as described (Chhabra et al., 2012).
For details of the antibodies, see the Supplemental Experimental Procedures.
For demonstration of vascular branching, thick placental sections (3 mm) were
prepared by vibratome and three-dimensional images were constructed using
confocal microscopy. In situ hybridization was performed using digoxigenin
(DIG)-labeled RNA antisense or sense probes forGcm1 and the alkaline phos-
phatase reaction (Simmons et al., 2008).
Gene Expression Analysis
For microarray analysis of c-Met-deficient trophoblasts, a single cell suspen-
sion of E12.5 placentas was stained with PE-conjugated anti-CD9 antibody
and CD9+ trophoblasts were enriched using anti-PE antibody-magnetic
microbeads. Affymetrix MOE430_2.0 microarrays were performed on two
independent WT and two c-Met g-KO CD9+ trophoblasts. Details about
microarray analysis and primer sequences (Table S3) are available in the
Supplemental Experimental Procedures.
Statistical Analysis
For statistical analysis, Student’s unpaired two-tailed t test was used for all
comparisons.
ACCESSION NUMBERS
The Gene Expression Omnibus accession number for the microarray data
reported in the paper is GSE38342.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables can be found with this article online at http://dx.
doi.org/10.1016/j.devcel.2013.10.019.
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